Aumoltertinib is a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and has achieved potent efficacy for advanced EGFR-mutated non-small cell lung cancer patients. Phase 2 non-randomized clinical trial was conducted at…
Tag: Treatment of Lung Cancer
Tarlatamab Shows Improved Overall Survival Over Chemotherapy in SCLC
Tarlatamab received accelerated approval for treatment of patients with previously treated small-cell lung cancer. It meaningfully improved overall survival compared with Chemotherapy in SCLC patients that progressed on or after initial platinum-based…
Heart-Sparing Technique in Lung Cancer Radiotherapy
A new study has been presented at ESTRO 2025 introducing RAPID-RT study. It utilizes an innovative rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. It offers a more inclusive…
Metformin Appears To Fight Lung Cancer But Only In Overweight Patients
Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about 20 million…
FDA Approves New Drug for Lung Cancer
Lung cancer is one of the leading causes behind cancer related deaths. Various studies and research works are going on to help lung cancer patients to get cure from this disease. Time-to-time,…
Study Utilizes Nanomedicine Using Gas Bubbles For Lung Cancer Treatment
Lung cancer is the most common forms of cancer and the leading cause of deaths. A recent study has been published in the European Journal of Pharmaceutical Sciences. According to this study,…
Tarlatamab for Small Cell Lung Cancer
Lung cancer is the second most form of cancers and remains the leading cause of cancer deaths. A variety of new treatments are helping to bring down the number of deaths from…
Study: Physical Tests Vital in Treating Metastatic Lung Cancer
According to a new study from the researchers in Brazil and the United States, simple physical tests like sitting down, standing up and walking can significantly aid physicians in managing treatments for…